arrow
L

Lillian Tugume

Makerere University
H指数:24
被引数:1,808

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis

成人结核性脑膜炎大剂量口服利福平的试验

2025-12-183
PRE
Cerebral Perfusion Pressures and Implications on Clinical Outcomes and Medical Management in Cryptococcal Meningitis

脑灌注压及对隐球菌性脑膜炎临床结局与医疗管理的影响

2025-08-010
OAAI
Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis

脑脊液白细胞浸润和激活的神经免疫介质对HIV相关性隐球菌性脑膜炎生存的影响

2025-02-100
OAAI
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022

2010年至2022年乌干达HIV相关隐球菌性脑膜炎的演变

2025-01-081
PRE
Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis
2024-08-280
PRE
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study

在乌干达实施基于两性霉素b脂质体的单次大剂量诱导治疗HIV相关隐球菌性脑膜炎: 一项比较前瞻性队列研究

2024-08-241
OAAI
Cryptococcal meningitis
2023-11-0924
PRE
Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV
2023-09-191
OAAI
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
2023-08-2233
OA
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial
2022-12-0118
OAAI
Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics
2022-03-3029
OAAI
High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial

大剂量口服和静脉注射利福平治疗主要是人类免疫缺陷病毒 (HIV) 阳性的乌干达成年人的结核性脑膜炎: 一项II期开放标签随机对照试验

2021-03-0851
OAAI
Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis

脑脊液乳酸可作为隐球菌性脑膜炎疾病严重程度和死亡率的预后指标

2020-11-2817
OAAI
Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis

基线血清C反应蛋白水平预测隐球菌性脑膜炎的死亡率

2020-10-294
OAAI